Results for pancreatic translation from English to Croatian

pancreatic
gušterača

pancreatic cancer
rak gušterače

increased pancreatic amylase
povišena pankreasna amilaza

pancreatic pseudocyst, subileus
pseudocista gušterače, subileus

monitoring of pancreatic function
nadzor funkcije gušterače

patients with pancreatic cancer:
bolesnici s rakom gušterače:

pancreatic neuroendocrine tumours (pnet)
neuroendokrini tumori gušterače (engl. pancreatic neuroendocrine tumours, pnet)

neuroendocrine tumours of pancreatic origin
neuroendokrini tumori s primarnim sijelom u gušterači

nausea1, 3, increased pancreatic amalyse1
mučnina1,3, povišena pankreasna amilaza1

abnormal results of pancreatic function tests
poremećeni rezultati testova funkcije gušterače

dose adjustments during treatment of pancreatic adenocarcinoma
prilagodbe doza tijekom liječenja adenokarcinoma pankreasa

pancreatic digest of casein disodium phosphate dihydrate
hidrolizirana želatina pankreasni digest kazeina dinatrijev fosfat dihidrat

if you have or have had pancreatic or gallbladder disorders.
ako imate ili ste ranije imali poremećaje gušterače ili žučnog mjehura.

advanced neuroendocrine tumours of pancreatic origin (pnet)
uznapredovali neuroendokrini tumori s primarnim sijelom u gušterači (pnet)

abnormal blood tests including pancreatic and liver enzymes.
poremećene krvne pretrage, uključujući enzime gušterače i jetre.

change in pancreatic function blood test results (amylase)
promjena u rezultatima pretraga krvi za funkciju gušterače (amilaza)

increase of pancreatic enzymes (such as lipase and amylase).
porast enzima gušterače (kao što su lipaza i amilaza).

glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.
glimepirid djeluje uglavnom tako da potiče oslobađanje inzulina iz beta stanica gušterače.

upon oral administration, pancreatic lipases hydrolyse glycerol phenylbutyrate and release pba.
nakon peroralne primjene, lipaze gušterače hidroliziraju glicerolfenilbutrat i oslobađaju pba.

(5) progression of pre-existing pancreatic adenocarcinoma with kras mutation.
(5) progresija postojećeg adenokarcinoma gušterače s mutacijom gena kras.